|Title:||Primary treatment and prognostic factors of carcinosarcoma of the ovary, fallopian tube, and peritoneum: A Taiwanese Gynecologic Oncology Group study||Authors:||I-HUI CHEN||Keywords:||Carcinosarcoma; Malignant mixed M?llerian tumor; Ovarian cancer||Issue Date:||2014||Journal Volume:||24||Journal Issue:||3||Start page/Pages:||506-512||Source:||International Journal of Gynecological Cancer||Abstract:||
Objective: This study aimed to determine the clinical prognostic factors involved in carcinosarcoma of the ovary, fallopian tube, and peritoneum. Materials and Methods: This retrospective study was undertaken by the Taiwanese Gynecologic Oncology Group. The retrieved clinical data included demographic characteristics, medical disease, tumor status, extent of surgery, and adjuvant chemotherapy. Results: In total, 63 patients with carcinosarcoma of the ovary, fallopian tube, and peritoneum were identified. Sixty-one patients with complete datawere enrolled for further data analysis. The mean follow-up period was 1.0 year, and the mean overall survival was 15.4 months. By log-rank tests, age, menopausal status, parity, hypertension, diabetes, primary tumor size, para-aortic lymph node metastasis, pretreatment CA-125, preceding diagnostic surgery, hysterectomy, lymphadenectomy, other surgeries, and paclitaxel use were not predictive of overall survival. Omentectomy, no gross residual implants after surgery, platinum treatment, and no pelvic lymph node metastasis had a trend toward better survival. Early diagnosis at stage I and cisplatin/ifosfamide regimen were significant associated with a better overall survival in logrank and simple Cox regression tests. Bilateral ovarian tumors and metastatic tumors larger than 2 cm were significantly associated with a poorer overall survival. Conclusions: Early diagnosis at stage I, unilateral ovarian tumor, metastatic tumors less than 2 cm, and cisplatin/ifosfamide regimen were predictive of a better survival. Omentectomy and complete debulking surgery also showed a trend toward better survival. Thus, these treatment strategies should be applied in patients with carcinosarcoma of the ovary, fallopian tube, and peritoneum. Ifosfamide, Paclitaxel, Debulking operation Copyright ? 2014 by IGCS and ESGO.
|DOI:||10.1097/IGC.0000000000000083||SDG/Keyword:||CA 125 antigen; carboplatin; cisplatin; ifosfamide; paclitaxel; adult; age; aged; article; cancer adjuvant therapy; cancer combination chemotherapy; cancer prognosis; cancer size; cancer staging; cancer surgery; cancer survival; carcinosarcoma; demography; diabetes mellitus; early diagnosis; female; follow up; human; hypertension; hysterectomy; laparoscopic surgery; laparotomy; lymph node dissection; lymph node metastasis; major clinical study; menopause; omentectomy; ovariectomy; ovary carcinoma; overall survival; paraaortic lymph node; parity; pelvis lymph node; pelvis lymphadenectomy; peritoneum cancer; primary tumor; priority journal; retrospective study; salpingooophorectomy; survival prediction; uterine tube carcinoma; adolescent; carcinosarcoma; clinical trial; epidemiology; Fallopian Tube Neoplasms; middle aged; mortality; multicenter study; Ovarian Neoplasms; Peritoneal Neoplasms; prognosis; Taiwan; very elderly; young adult; Adolescent; Adult; Aged; Aged, 80 and over; Carcinosarcoma; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Taiwan; Young Adult
|Appears in Collections:||醫學院附設醫院 (臺大醫院)|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.